For research use only. We do not sell to patients.
SGL5213
CAS No. : 1240305-17-2
Biological Activity：SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment.
Research Area：Metabolic Disease
Targets：SGLT
Related Small Molecules:Luseogliflozin;Tofogliflozin;Mizagliflozin;Trilobatin;TA-1887;SGLT inhibitor-1;Sotagliflozin;Phloretin;Ertugliflozin L-pyroglutamic acid;Ipragliflozin (L-Proline);LX2761;Enavogliflozin;T-1095;HSK0935;Ipragliflozin-d5;Velagliflozin;Kushenol K;Remogliflozin etabonate
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
